**Blog post by team supervisor Ann Dorlet
I had the pleasure of attending the National Autism Conference at Penn State with some wonderful work colleagues. The Penn State conference is an intimate affair with some prominent speakers. Among them were some of our Head Consultants here at BACA. Dr.’s John and Barb Esch presented on Treatment Integrity, IOA and Vocal Training Procedures. Dr. Mark Sundberg was there giving the attendee’s a review of the VB-MAPP and its many uses within the clinical and education setting. Dr. Peter Gerhardt was there, too, discussing the important skills needed to successfully transition to employment and life in the community.
One presentation that I attended was Dr. Eb Blakely’s on Behavioral Pharmacology. Dr. Blakely did a great job reviewing the most common types of medications used by individuals diagnosed with autism (e.g. anti-depressants, anti-convulsants, anti-anxiety drugs) and made some key points during his presentation, one being that a majority of individuals on the spectrum take prescription medications. It is important for us as behavior analysts and service delivery practitioners to be aware of these types of medications and to know the possible side effects associated with them. He also stressed the importance of parents being active participants in evaluating these medications.
Dr. Blakely also reviewed procedures on what to do if you have a parent who decides to start their child on medication during behavior intervention and how to evaluate the effects of a medication during treatment. These procedures are outlined in his PowerPoint presentation. If you would like more information, please feel free to contact me (email@example.com) and I can send it to you via email.
If any of you would like to watch Dr. Blakely’s presentation, you can access the webcast via the National Autism Conference homepage at: